APA (7th ed.) Citation

Yan, J., Zhuang, L., Wang, Y., Jiang, Y., Tu, Z., Dong, C., . . . Zhu, Y. (2022). Inhibitors of cell cycle checkpoint target Wee1 kinase - a patent review (2003-2022). Expert opinion on therapeutic patents, 32(12), 1217-1244. https://doi.org/10.1080/13543776.2022.2166827

Chicago Style (17th ed.) Citation

Yan, Jingxue, Lili Zhuang, Yong Wang, Yiqing Jiang, Zhenlin Tu, Chao Dong, Yadong Chen, and Yong Zhu. "Inhibitors of Cell Cycle Checkpoint Target Wee1 Kinase - a Patent Review (2003-2022)." Expert Opinion on Therapeutic Patents 32, no. 12 (2022): 1217-1244. https://doi.org/10.1080/13543776.2022.2166827.

MLA (9th ed.) Citation

Yan, Jingxue, et al. "Inhibitors of Cell Cycle Checkpoint Target Wee1 Kinase - a Patent Review (2003-2022)." Expert Opinion on Therapeutic Patents, vol. 32, no. 12, 2022, pp. 1217-1244, https://doi.org/10.1080/13543776.2022.2166827.